Prevalence of peptic ulcer in Iran: Systematic review and meta analysis methods

Similar documents
Helicobacter Pylori Testing HELICOBACTER PYLORI TESTING HS-131. Policy Number: HS-131. Original Effective Date: 9/17/2009

Corporate Medical Policy

Urea Breath Test for Diagnosis of Helicobactor pylori. Original Policy Date 12:2013

DERBYSHIRE JOINT AREA PRESCRIBING COMMITTEE (JAPC) MANAGEMENT OF DYSPEPSIA

Work interest: Reviewer in the journals: Editorial board:

KK College of Nursing Peptic Ulcer Badil D ass Dass, Lecturer 25th July, 2011

The significance of Helicobacter pylori in the approach of dyspepsia in primary care Arents, Nicolaas Lodevikus Augustinus

GASTROINTESTINAL AND ANTIEMETIC DRUGS. Submitted by: Shaema M. Ali

Peptic ulcer disease Disorders of the esophagus

MANAGEMENT OF DYSPEPSIA AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD)

Helicobacter 2008;13:1-6. Am J Gastroent 2007;102: Am J of Med 2004;117:31-35.

June By: Reza Gholami

Epidemiology of Peptic Ulcer Disease

Association between Helicobacter pylori, caga, and vaca Status and Clinical Presentation in Iranian Children

Duodenal Ulcer / Duodenitis

Clinical Policy Title: Noninvasive testing for H. pylori

GI update. Common conditions and concerns my patients frequently asked about

Clinical Policy Title: Noninvasive testing for H. pylori

Association of Helicobacter pylori infection with Atrophic gastritis in patients with Dyspepsia

Management of dyspepsia and of Helicobacter pylori infection

National Digestive Diseases Information Clearinghouse

Low Dose Furazolidone for Eradication of H- pylori Instead of Clarithromycin: A Clinical Trial

Guidelines for the Management of Dyspepsia and GORD. Gastroenterology/ Acute Adult Governance. Drugs and Therapeutics Committee

PEPTIC ULCER DISEASE JOHN R SALTZMAN, MD. Director of Endoscopy Brigham and Women s Hospital Professor of Medicine Harvard Medical School

Policy Evaluation: Proton Pump Inhibitors (PPIs)

Helicobacter and gastritis

Management of Dyspepsia

Helicobacter pylori: Diagnosis, treatment and risks of untreated infection

CHAPTER 18. PEPTIC ULCER DISEASE, SELF-ASSESSMENT QUESTIONS. 1. Which of the following is not a common cause of peptic ulcer disease (PUD)?

Peptic ulcer disease. Nomin-Erdene. D SOM-531

Original article J Bas Res Med Sci 2015; 2(4):45-50.

Gastro-oesophageal reflux disease and peptic ulcer disease. By: Dr. Singanamala Suman Assistant Professor Department of Pharm.D

Treatment of Helicobacter pylori Infection

Magaji et al., Afr. J. Infect. Dis. 2(2): THE ROLE OF AN AGGRESSIVE FACTOR IN PEPTIC ULCER DISEASE (PUD)

Research Article Concomitant Colonization of Helicobacter pylori in Dental Plaque and Gastric Biopsy


ACG Clinical Guideline: Treatment of Helicobacter pylori Infection

Index. Note: Page numbers of article titles are in boldface type.

ALL YOU NEED TO KNOW ABOUT INDIGESTION FUNDING RESEARCH INTO DISEASES OF THE GUT, LIVER & PANCREAS

Disclosures. Co-founder and Chief Science Officer, TechLab

Clinical Trial of Efcid (Himcocid) in Patients of Acid Peptic Disease

The Nobel Prize in Physiology or Medicine for 2005

Clinical Policy Title: Noninvasive testing for H. pylori

REVIEW ARTICLE. Prevalence of Epilepsy in Iran: A Meta-Analysis and Systematic Review

Clinical Policy Title: Breath Testing for H. Pylori

Comparative study of invasive methods for diagnosis of Helicobacter pylori in humans

SARCINA VENTICULARI IS A POSSIBLE CAUSATIVE MICROORGANISM OTHER THAN H.PYLORI IN GASTRIC OUTLET OBSTRUCTION PATHOGENESIS

Peptic Ulcer Disease Update

Gastric Ulcer / Gastritis

MEDICAL POLICY EFFECTIVE DATE: 05/19/11 REVISED DATE: 05/24/12, 05/23/13 ARCHIVED DATE: 05/22/14 EDITED DATE: 05/28/15, 05/25/16, 05/18/17, 05/17/18

GASTROINTESTINAL SYSTEM MANAGEMENT OF DYSPEPSIA

Efficacy of standard triple therapy versus bismuth-based quadruple therapy for eradication of Helicobacter Pylori infection

What Is Peptic Ulcer Disease?

Drug Class Review on Proton Pump Inhibitors

Prevalence of gastroduodenal lesions in chronic nonsteroidal anti-inflammatory drug users presenting with dyspepsia at the Kenyatta National Hospital

Zantac for stomach ulcers

Indigestion (1 of 5) What is indigestion? What causes indigestion?

KEYWORDS Dyspepsia, Acid Peptic Disease, Helicobacter Pylori, Urease, Giemsa, Peptic Ulcer, Non-Ulcer Dyspepsia.

Gilles Jequier. Commercial Director Organobalance, a Novozymes Company

PRESCRIBING SUPPORT TEAM AUDIT: PROTON PUMP INHIBITOR PRESCRIBING REVIEW

Dyspepsia is a problem commonly seen by primary

Proton Pump Inhibitors Drug Class Prior Authorization Protocol

What is the status of Sequential Therapy Versus Standard Triple- Drug Therapy in peptic ulcer disease in eradicating H pylori?

EDUCATION PRACTICE. Persistent Helicobacter pylori Infection After a Course of Antimicrobial Therapy What s Next? Clinical Scenario.

The usual dose is 40 mg daily with amoxycillin 1.5 g (750 mg b.d.) for 2 weeks. Up to 2 g/day of amoxycillin has been used in clinical trials.

Second term/

Famotidine Extended Abstracts

Management of dyspepsia in adults in primary care

Summary of Findings on the Prescribing and Use of Proton Pump Inhibitors. COMPUS Interim Report CCOHTA. March 6, 2006

GI Pharmacology. Dr. Alia Shatanawi 5/4/2018

One-third of adults experience pain or discomfort in

Gastroenterology Fellowship Program

IgE levels are increased in patients with Helicobacter pylori infection

Stomach Pain Evidence-Based Methods in the Diagnosis and Treatment of Dyspepsia

PPIs: Good or Bad? 1. Basics of PPIs. Gastric Acid Basics. Outline. Gastric Acid Basics. Proton Pump Inhibitors (PPI)

Peptic Ulcer Disease and NSAIDs

Peptic Ulcers. What I need to know about. hvordan man vælger en børnelæge med speciale i astma. National Digestive Diseases Information Clearinghouse

Table 2.9. Case control studies of helicobacter pylori infection and oesophageal adenocarcinoma

6/25/ % 20% 50% 19% Functional Dyspepsia Peptic Ulcer GERD Cancer Other

Correlation Between Endoscopic and Histological Findings in Different Gastroduodenal Lesion and its Association with Helicobacter Pylori

QUICK QUERIES. Topical Questions, Sound Answers

Gastroenterology. Certification Examination Blueprint. Purpose of the exam

Fecal incontinence causes 196 epidemiology 8 treatment 196

Upper Gastrointestinal Manifestations in Chronic Renal Failure Through Upper Gastrointestinal Endoscopy

Functional Dyspepsia. Norbert Welkovics Heine van der Walt

The association of and -related gastroduodenal diseases

HELICOBACTER PYLORI; PATIENTS WITH FUNCTIONAL DYSPEPSIA

Philadelphia College of Osteopathic Medicine. Shawn P. Mahoney Philadelphia College of Osteopathic Medicine,

COMPARISON OF ONCE-A-DAY VERSUS TWICE-A-DAY CLARITHROMYCIN IN TRIPLE THERAPY FOR HELICOBACTER PYLORI ERADICATION

Rpts. GENERAL General Schedule (Code GE) Program Prescriber type: Dental Medical Practitioners Nurse practitioners Optometrists Midwives

Surgery for Complications of Peptic Ulcer Disease (Definitive Treatment)

UPPER GI DISEASES 11/15/2014. Lesson Objectives. GI Tract Review. NUTR 2050 Nutrition for Nursing Professionals. Mrs. Deborah A. Hutcheon, MS, RD, LD

Sensitivity to nitazoxanide among metronidazole resistant Helicobacter pylori strains in patients with gastritis

Clinical Policy Title: Noninvasive testing for H. pylori

A Trip Through the GI Tract: Common GI Diseases and Complaints. Jennifer Curtis, MD

The Association of CagA + Helicobacter pylori Infection and Gastric Carcinoma

Setting The setting was primary care. The economic study was conducted in Canada.

Transcription:

Review Article Prevalence of peptic ulcer in Iran: Systematic review and meta analysis methods Kourosh Sayehmiri, Ghobad Abangah 1, Gholamreza Kalvandi 2, Hamed Tavan 3, Sanaz Aazami 4 Departments of Community Medicine, Faculty of Medicine, Psychosocial Injuries Research Center, 1 Department of Gastroenterology, Faculty of Medicine, 2 Departments of Pediatrics and Medicine, Faculty of Medicine, 3 Department of Nursing, Students Research Committee, 4 Department of Nursing, Faulty of Nursing and Midwifery, Ilam University of Medical Science, Ilam, Iran Background: Peptic ulcer is a prevalent problem and symptoms include epigastria pain and heartburn. This study aimed at investigating the prevalence and causes of peptic ulcers in Iran using systematic review and meta-analysis. Materials and Methods: Eleven Iranian papers published from 2002 to 2016 are selected using valid keywords in the SID, Goggle scholar, PubMed and Elsevier databases. Results of studies pooled using random effects model in meta-analysis.the heterogeneity of the sample was checked using Q test and I 2 index. Results: Total sample size in this study consist of 1335 individuals with peptic ulcer (121 samples per article). The prevalence of peptic ulcers was estimated 34% (95% CI= 0.25 0.43). The prevalence of peptic ulcers was 30% and 60% in woman and man respectively. The highest environmental factor (cigarette) has been addressed in 30% (95% CI= 0.23-0.37) of patients. The prevalence of Helicobacter pylori was estimated in 62% (95% CI= 0.49-0.75) of patients. Conclusion: The results of this study show that prevalence of peptic ulcers in Iran (34%) is higher that worldwide rate (6% to 15%). There was an increasing trend in the prevalence of peptic ulcer over a decade from 2002 to 2016. Key words: Peptic ulcers, Iran, Prevalence, Causes, Meta-analysis, Systematic review How to cite this article: Sayehmiri K, Abangah G, Kalvandi G, Tavan H, Aazami S. Prevalence of peptic ulcer in Iran: Systematic review and metaanalysis methods. J Res Med Sci 2018;23:8. INTRODUCTION Peptic ulcer, also known as stomach ulcer, is a break in the lining of stomach, first part of the small intestine and sometimes in the lower esophagus. Gastric acid is well described as the cause of peptic ulcer, while Helicobacter pylori infection is recognized as the major causative factor in ulcer formation. The bacterium causes stimulation in the production of gastric acid due to gastritis, and this cycle contributes to erosion of the mucosa and ulcer formation. In addition, imbalance between offensive factors (excessive gastric acid, H. pylori, gallbladder fluid, and elevated free radicals) and defensive factors (mucosa, blood fluid, prostaglandins, and antioxidants) may also lead to peptic ulcer. Therefore, the effective first line treatment is antibiotic therapy. Peptic ulcers are present at around 6% 15% of the population. [1,2] Factors that increase Access this article online Quick Response Code: Website: www.jmsjournal.net DOI: 10.4103/jrms.JRMS_1035_16 risk of developing peptic ulcer include smoking, older individuals, O blood type, and stress. Peptic ulcers that tend to heal longer than duodenal ulcer are at higher risk of developing gastritis and gastric malignancy. [3,4] Sign and symptoms of peptic ulcer may include one of the following; epigastric pain (strongly correlated to mealtimes), gastroesophageal reflux, dyspepsia, and melena (presence of blood in the stool). The two most common types of indigestions are peptic ulcer disease (PUD) and nonulcer dyspepsia (NUD). NUD is a prevalent disease in several countries such as Iran. [5] Medication therapy is an effective treatment for peptic ulcer, and usually, combination of drugs is required for the ultimate effect. Patients should be able to tolerate medications and adhere to the prescribed regimen. [6] Diagnosis test for H. pylori could be noninvasive methods such as stool antigen test and blood antigen test. However, the most accurate methods to detect H. pylori are invasive approaches that require histological This is an open access article distributed under the terms of the Creative Commons Attribution NonCommercial ShareAlike 3.0 License, which allows others to remix, tweak, and build upon the work non commercially, as long as the author is credited and the new creations are licensed under the identical terms. For reprints contact: reprints@medknow.com Address for correspondence: Mr. Hamed Tavan, Psychosocial Injuries Research Center, Ilam University of Medical Sciences, Ilam, Iran. Department of Nursing, Faculty of Nursing and Midwifery, Ilam University of Medical Science, Ilam, Iran. E mail: hamedtavan@gmail.com Received: 16 03 2017; Revised: 10 05 2017; Accepted: 21 11 2017 1 2018 Journal of Research in Medical Sciences Published by Wolters Kluwer - Medknow 2018

examination after endoscopic biopsy as well as rapid urease test and microbial culture. [7,8] Medications for treating peptic ulcer include one of the following drug categories; anti acid drugs (e.g., magnesium hydroxide), proton pumps blockers (e.g., omeprazole), H 2 blockers (e.g., ranitidine and cimetidine), as well as cytoprotective agent (e.g., bismuth subsalicylate). [9] Complications may include gastrointestinal bleeding (GIB), perforation, spillage of the acid or stomach content into the abdominal cavity, blockage of the stomach, and developing gastric malignancy. [10] Serious complications include duodenal perforation, GIB, and gastrointestinal obstruction. [11] Nowadays, surgical procedure for the treatment of uncomplicated peptic ulcer became obsolete. However, surgery typically is used in case of pyloric stenosis and drug resistant peptic ulcers. There are several studies assessed cause and complications of peptic ulcers in Iran. [4] In the previous meta analysis done, prevalence of peptic ulcer in Iran was estimated, [4] but the prevalence of peptic ulcer causes was not considered in this study. However, a meta analysis is lacking to validate the results of existing knowledge and to open platform for potential use in the clinical practice and preventive medicine. The aim of this study is to determine cause and consequences of peptic ulcer in Iran, concerning the geographical area, age, and risk factors. MATERIALS AND METHODS Search strategy This is a systematic review and meta analysis study of the literature on peptic ulcer. Electronic databases including Google, Google Scholar, Scientific Information Database, PubMed, Scopus, and Elsevier were searched for published articles in the Persian and English language. Several keywords were used for the search including peptic ulcer, prevalence peptic ulcer in Iran, cause of peptic ulcer, complications of peptic ulcer, and consequence of peptic ulcer. Selection of studies and data extraction Two investigators independently collected initial list of studies with primary outcome of interest on peptic ulcer, cause, and consequences in Iran. Studies that assess solely treatment of peptic ulcer and risk factors were excluded from the list. A standardized data extraction template was used to provide a primary checklist of included studies. This checklist includes author name, title, year, location of study, sample size, population, gender, prevalence of peptic ulcer in total sample, prevalence of peptic ulcer among male and female, age category, and risk factors of peptic ulcer. The final checklist was generated by selecting studies that meet the criteria for the present meta analysis. According to our strategy, 80 studies were included into the primary checklist and resulted into final inclusion of 50 articles for this study. However, 30 selected articles were checked again for the secondary outcome of interest, including sample size, time of data collection, and prevalence of peptic ulcer in Iran. Finally, 11 articles met the criteria to be included in the study and their full text was assessed. Data analysis We preferred to use the binomial distribution of meta analysis to model within study variability. An overall prevalence is calculated as a weighted average of the individual studies. Each study weighted inversely proportional to its variance. We incorporated random effect model in this study due to significant heterogeneity index. Level of heterogeneity in this study was 89.6%, which indicates high heterogeneous studies. Heterogeneity <25% is defined as low heterogeneous, between 25% and 75% is defined as moderate heterogeneity falls, and more than 75% is defined as high heterogeneous. RESULTS Systematic review of literature was conducted which yielded into identification of 80 articles. After careful consideration of titles and abstracts, 50 articles were included into the primary checklist. Finally, 11 articles met the inclusion criteria to be included into the final analysis of the current meta analysis study [Figure 1]. The eleven eligible studies reported prevalence of peptic ulcer in Iran during 2002 2016 with total combined sample size of 1335 (121 sample per article). In terms of geographical distribution, 72.72% of the studies were conducted in central part of Iran (5 in Tehran, 1 in Qazvin, and 2 in Isfahan), 18.18% in the northwestern area (1 in Tabriz, 1 in Sanandaj), and 9% in the east area (1 in Kerman). Sampling method within the entire selected studies used selection from list of eligible individuals and all of the studies employed cross sectional design. The 11 eligible studies reported prevalence and cases of peptic ulcer in general with the lowest prevalence in Qazvin (in 2005 and estimated to be 0.136) and the highest prevalence (0.545) in Sanandaj (2016). The characteristics of selected articles are presented in Table 1. The prevalence of peptic ulcer among women with 95% confidence interval (CI) was 30% (0.19 0.41) and among men with 95% CI was 60% (0.53 0.67) and average overall was 34% (0.25 0.43). The prevalence of peptic ulcer among women was 30% (95% CI = 0.23 0.37, I 2 = 89.61, P < 0.001) and among men was 60% (95% CI = 0.53 0.67, I 2 = 54.71, P < 0.05). However, the overall prevalence of peptic ulcer was 34% (95% CI = 0.25 0.43, I 2 = 92%, P = 0.000). As a result of a significant Journal of Research in Medical Sciences 2018 2

heterogeneity (I 2 = 89.6%), meta analyses were conducted using the random effects model as depicted in Figure 2. In Figure 3, the clinical manifestations of peptic ulcer have been reported and show that in 83% of patients, one or more of these clinical manifestations existed (epigastric pain, belching, histories, bloating, vomit, early fullness, anorexia, and nausea). In Figure 4, the highest environmental factor (cigarette) has been addressed and 30% (95% CI = 0.23 0.37, I 2 = 82.6%, P = 0.000) have smoked. In Figure 5, the highest internal factor (H. pylori) was evaluated and the results showed that in 62% (95% CI = 0.49 0.75, I 2 = 93.2%, P = 0.000) of patients, this bacterium was present. Meta regression indicates that studies with low sample size reported higher prevalence and cases of peptic ulcer [Figure 6]. The prevalence and cases of peptic ulcer over time are shown in Figure 7 with an increasing trend from 2002 to 2015. Figure 8 depicts the symmetric funnel shape plot implying the absence of publication bias in this meta analysis. According to our findings, 66.66% of the peptic ulcers were diagnosed through endoscopy and 33.33% through biopsy. The most vulnerable group for developing peptic ulcer was aged between 40 and 45 years and the frequent symptoms were epigastric pain and heartburn. 50 articles excluded 19 articles excluded Initially, 80 articles were included in primary list 30 articles examined and included into primary checklist 11 articles were included into full-text analysis Figure 1: Flowchart of search strategy and number of studies included DISCUSSION This systematic review and meta analysis showed that peptic ulcer is prevalent among Iranian individuals aged 40 45 years with overall prevalence of 41%. Prevalence of peptic ulcer in Iran ranged from 13.6% [12] to 47.2%. [13] In addition, we have examined gender specific prevalence of peptic ulcer and found that men are more prone to develop such disease than women. This finding is consistent with the previous studies conducted in Iran and found higher prevalence of peptic ulcer among men. [2,6,12] Level of heterogeneity in this study was 89.6%, which indicates high heterogeneous studies. Heterogeneity <25% is defined as low heterogeneous, between 25% and 75% is defined as moderate heterogeneity falls, and more than 75% is defined as high heterogeneous. Therefore, we used random effect model within this meta analysis to adjust for the expected differences between studies (due to examination of heterogeneous studies). According to this model, it is hypothesized that observed differences are due to diverse samples and different measurement. Our findings showed that the least prevalence of peptic ulcer is attributed to Qazvin (136 in 1000 population), while the highest belongs to Sanandaj (547 in 1000 population). The prevalence of peptic ulcer in this meta analysis was 34%, which is higher to the worldwide prevalence of peptic ulcer (reported from 6% to 15%). [1,2] The present meta analysis showed that risk factors for peptic ulcer are H. pylori and smoking. In addition, most common symptoms were epigastric pain as well as heartburn. These findings are consistent with the previous studies in Iran. [14,15] The most vulnerable group for developing peptic ulcer was aged between 40 and 45 years which is in line with the previous evidence. [2,6,13] We found an increasing trend in the prevalence of peptic ulcer over time from 2002 to 2015. In addition, we found that men are more likely to develop peptic ulcer compared to women. A possible explanation for this finding is higher rate of smoking among men, which Table 1: Characteristics of included studies with regard to the prevalence of peptic ulcer References First author Place Year Sample size Mean age Women Men Prevalence of peptic ulcer [2] Kalantari Isfahan 2010 120 35.6 366 633 0.367 [6] Goudarzi Tehran 2012 84 56.6 333 620 0.380 [12] Hajagamohammadi Qazvin 2005 125 41.2 136 512 0.488 [13] Vahidi Tehran 2002 72 48.3 472 555 0.445 [14] Vafaie Tabriz 2005 200 580 700 0.300 [15] Shirazi Tehran 2005 150 217 520 0.480 [16] Yazdanpanah Sanandaj 2016 90 47.5 20 70 0.545 [17] Mirzaei Kerman 2015 215 62 81 134 0.214 [18] Salari Tehran 2009 50 45.5 21 29 0.500 [19] Rajabalinia Tehran 2012 136 55.9 51 85 0.162 [20] Ashrafi Hafez Isfahan 2013 93 38.54 43 50 0.500 3 Journal of Research in Medical Sciences 2018

Figure 2: Prevalence of peptic ulcer with 95% confidence interval in the studies. Each line shows 95% confidence interval; diamond shows overall effects of studies. Overall prevalence of partial and total peptic ulcer using the random effects model. Each square represents the effect estimates for each individual study. Their confidence interval for peptic ulcer prevalence is reflected by the size of each square proportional to the weight assigned to each study within the meta analysis. The diamond represents the overall pooled results Figure 3: Prevalence of peptic ulcer with 95% confidence interval in the studies. Each line shows 95% confidence interval; diamond shows overall effects of studies. Overall Clinical manifestations of peptic ulcer of partial and total peptic ulcer using the random effects model. Each square represents the effect estimates for each individual study. Their confidence interval for clinical manifestations of peptic ulcer is reflected by the size of each square proportional to the weight assigned to each study within the meta analysis. The diamond represents the overall pooled results Figure 4: Prevalence of peptic ulcer with 95% confidence interval in the studies. Each line shows 95% confidence interval; diamond shows overall effects of studies. Overall smoking and peptic ulcer of partial and total peptic ulcer using the random effects model. Each square represents the effect estimates for each individual study. Their confidence interval for smoking and peptic ulcer is reflected by the size of each square proportional to the weight assigned to each study within the meta analysis. The diamond represents the overall pooled results eventually increase chance of developing peptic ulcer. Therefore, health promotion and empowerment programs to help individuals quit smoking may also play an important role in the prevention of PUD. Raise individuals awareness on symptoms of peptic ulcer (epigastric pain and heartburn) helps them to seek care, which leads to early diagnosis and good prognosis. According to the results of the study, 83% of patients had clinical manifestations (epigastric pain, belching, histories, bloating, vomit, early fullness, anorexia, and nausea); it seems that these symptoms are very useful in the diagnosis of peptic ulcer and should be suspected of ulcer in patients with such clinical manifestations. [16 18] Figure 5: prevalence of Helicobacter pylori in peptic ulcer patients with 95% confidence interval. Overall Helicobacter pylori and peptic ulcer of partial and total peptic ulcer using the random effects model. Each square represents the effect estimates for each individual study. Their confidence interval for Helicobacter pylori and peptic ulcer is reflected by the size of each square proportional to the weight assigned to each study within the meta analysis. The diamond represents the overall pooled results One of the environmental causes of peptic ulcer is smoking, which in the present study was 30% in patients with peptic ulcer. Smoking causes peptic ulcers and is more common in males, [19 20] which has led to a higher incidence of males than women, suggesting that cigarette smoking in males is reduced, and by educating and expressing the dangers of those people alert made. One of the causes of internal peptic ulcer is H. pylori. In the present study, it was 62% in patients with peptic ulcer. The presence of this bacterium almost determines the peptic ulcer. [16 20] Many factors contribute to the growth of this bacterium and cause stomach ulcer disease. It is suggested that screening tests performed on an annual basis should be performed more accurately and sensitively to those who are prone to peptic ulcer to be identified earlier, to prevent the onset of the disease. Journal of Research in Medical Sciences 2018 4

limited number of existing variables in the studies, and focusing on cause, consequence, and treatment of peptic ulcer without reporting its prevalence. In addition, there was no clear distinction between peptic and duodenal ulcer in some studies. We were not able to assess the prevalence of peptic ulcer in quintet geographical area of Iran (north, south, west, east, and center) due to the absence of conducted studies in all area. CONCLUSIONS Figure 6: Meta regression according to the sample size. Presentation of the relationship between sample size and peptic ulcer prevalence. Each circle represents the sample size, and as the volume of each circle increases, the sample size is increased The prevalence of peptic ulcer in Iran (34%) is higher than average reported worldwide rate (6% 15%), and there is an increasing trend over time. Our results showed that men are more prone to develop peptic ulcer than women are. According to the results of the study, 83% of patients had clinical manifestations (epigastric pain, belching, histories, bloating, vomit, early fullness, anorexia, and nausea). One of the environmental causes of peptic ulcer is smoking, which in the present study was 30% in patients with peptic ulcer. One of the causes of internal peptic ulcer is H. pylori. In the present study, it was 62% in patients with peptic ulcer. The presence of this bacterium almost determines the peptic ulcer. Financial support and sponsorship Ilam University of Medical Sciences (ILUMS). Conflicts of interest There are no conflicts of interest. Figure 7: Meta regression according to the year of studies. Increasing trend of peptic ulcer prevalence in the period between 2002 and 2015 in Iran Figure 8: Publication biases according to the prevalence and cases of peptic ulcer in Iran: symmetric funnel shape plot implying the absence of publication bias in this meta analysis Limitations There are several limitations in the selected studies for this meta analysis including nonrandom sample selection, REFERENCES 1. Ghahramani R, Abbasian AS, Shafaee S. Prevalence of celiac disease in patients with different types of dyspepsia. J Isfahan Med Sch 2009;27: 64-73. 2. Kalantari H, Nauruan SM. Prevalence of peptic ulcer versus non ulcer dyspepsia in patients which were admitted for endoscopy. J Isfahan Med Sch 2011;28: 44-53. 3. Abdollahi L, Zolfaghari MR, Amini M, Salehi R. The relation between microalbuminuria and Helicobacter pylori VacA gene in type 2 diabetic patients, Isfahan, Iran. J Isfahan Med Sch 2012;30 :228-37. 4. Tavan H, Sayehmiri K. Prevalence of peptic ulcer in Iran using the meta analysis and systematic review. GOVARESH 2016;20:250 8. 5. Talebi Bezmin Abadi A, Mohabati Mobarez A, Taghvaei T. An investigation of the prevalence of icea genotypes in Helicobacter pylori strains isolated from peptic ulcer patients in Sari (2008). Arak Med Univ J 2010;13:84 90. 6. Goudarzi H, Rezaee H, Rafizadeh M, Taghavi A, Mirsamadi E. The frequency of caga gene of H. pylori isolated from biopsy specimen in Tehran during 2008 2010. Arak Med Univ J 2012;15:42 8. 7. Karami L, Majd A, Mehrabian S, Nabiuni M, Irian S, Salehi M. Antimutagenic effects of ethanol and aqueous extracts of Avicennia marina leaves on Salmonella typhimurium TA100 bacterium. Arak Med Univ J 2013;15:68 76. 8. Mousavi F, Rahnema M, Heydarieh N, Tajabadi Ebrahimi M. The effect of Iranian native Lactobacillus pentosus on healing of gastric 5 Journal of Research in Medical Sciences 2018

ulcers in male Wister rats. Arak Med Univ J 2013;16:81 90. 9. Salemi Z, Kamali Pooya S, Ghasemi M. Secretor status and some risk factors in duodenal ulcer, gastric ulcer, and gastric cancer. Arak Med Univ J 2013;16:45 51. 10. Fazli D, Davarpanah Y, Amini B. Effects of examination stress on plasma levels of cortisol and hypertension. Sci J Ilam Univ Med Sci 2010;18:48-54. 11. Esmailnasab N, Taymoori P, Darabi F. Comparison of quality of life 3 and 9 months after surgery in patients with gastrointestinal cancer. J Urmia Univ Med Sci 2013;24:226-34. 12. Hajagamohammadi AA, Sheikholslami H, Esmaeili R. Prevalence of Helicobacter Pylori infection in different endoscopic lesions of patients in Qazvin Bouali Sina hospital (2002). J Qazvin Univ Med Sci 2005;9:68 72. 13. Vahidi SH, Azadegan M, Shakeri A. Comparison of cytology and histopathology in the diagnosis of Helicobacter pylori infection in contact with the stomach biopsy specimens. J Fac Med Univ Med Sci Health Serv Martyr Beheshti 2002;26:241 3. 14. Vafaie B, Golabi J. Surveying the association between life stresses and gastrointestinal diseases (peptic ulcer). J Fac Med Univ Med Sci Health Serv Martyr Beheshti 2004;28:285 9. 15. Shirazi MH, Ghasemi A, Khoramizadeh MR, Ebrahimi N, Hosaeini M, Sadeghifard N. Detection of caga gene in H. pylori strains isolated from patients with NUD, peptic ulcers and cancer by PCR. Sci J Ilam Univ Med Sci 2006;14:22 8. 16. Yazdanpanah K, Parhizkar B, Sheikhesmaeili F, Roshani M, Nayebi M, Gharib F. Efficacy of zinc sulfate in peptic ulcer disease: A Randomized Double Blind Clinical Trial Study. J Clin Diagn Res 2016;10:OC11 5. 17. Seyed Mirzaei SM, Zahedi MJ, Shafiei Pour S. Prevalence of Helicobacter Pylori negative, non steroidal anti inflammatory drug related peptic ulcer disease in patients referred to Afzalipour hospital. Middle East J Dig Dis 2015;7:241 4. 18. Salari MH, Shirazi MH, Ahmmadi M, Hadaiti N, Daryani A. Frequency of Helicobacter pylori vaca genotypes in Iranian patients with gastric and duodenal ulcer. J Infect Public Health 2009;2:204 8. 19. Rajabalinia H, Ghobakhlou M, Nikpour S, Dabiri R, Bahriny R, Jahani Sherafat S, et al. Non Helicobacter pylori, non NSAIDs peptic ulcers: A descriptive study on patients referred to Taleghani hospital with upper gastrointestinal bleeding. Gastroenterol Hepatol Bed Bench 2012;5:190 6. 20. Ashrafi Hafez A, Tavassoli E, Hasanzadeh A, Reisi M, Javadzade H, Imanzad M. Quality of life in peptic ulcer patients referring to Al Zahra hospital of Isfahan, Iran. Gastroenterol Hepatol Bed Bench 2013;6 Suppl 1:S87 92. Journal of Research in Medical Sciences 2018 6